1. Home
  2. BIO vs SRAD Comparison

BIO vs SRAD Comparison

Compare BIO & SRAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • SRAD
  • Stock Information
  • Founded
  • BIO 1952
  • SRAD 2001
  • Country
  • BIO United States
  • SRAD Switzerland
  • Employees
  • BIO N/A
  • SRAD N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • SRAD Computer Software: Programming Data Processing
  • Sector
  • BIO Industrials
  • SRAD Technology
  • Exchange
  • BIO Nasdaq
  • SRAD Nasdaq
  • Market Cap
  • BIO 7.7B
  • SRAD 9.0B
  • IPO Year
  • BIO N/A
  • SRAD 2021
  • Fundamental
  • Price
  • BIO $297.20
  • SRAD $25.42
  • Analyst Decision
  • BIO Strong Buy
  • SRAD Strong Buy
  • Analyst Count
  • BIO 4
  • SRAD 17
  • Target Price
  • BIO $333.50
  • SRAD $30.59
  • AVG Volume (30 Days)
  • BIO 214.4K
  • SRAD 2.4M
  • Earning Date
  • BIO 10-29-2025
  • SRAD 11-06-2025
  • Dividend Yield
  • BIO N/A
  • SRAD N/A
  • EPS Growth
  • BIO N/A
  • SRAD 359.43
  • EPS
  • BIO 11.49
  • SRAD 0.43
  • Revenue
  • BIO $2,554,200,000.00
  • SRAD $1,399,017,029.00
  • Revenue This Year
  • BIO $2.12
  • SRAD $19.11
  • Revenue Next Year
  • BIO $2.90
  • SRAD $16.92
  • P/E Ratio
  • BIO $25.93
  • SRAD $58.77
  • Revenue Growth
  • BIO N/A
  • SRAD 19.37
  • 52 Week Low
  • BIO $211.43
  • SRAD $11.72
  • 52 Week High
  • BIO $387.99
  • SRAD $32.22
  • Technical
  • Relative Strength Index (RSI)
  • BIO 58.13
  • SRAD 25.19
  • Support Level
  • BIO $266.71
  • SRAD $25.91
  • Resistance Level
  • BIO $286.84
  • SRAD $27.40
  • Average True Range (ATR)
  • BIO 8.86
  • SRAD 0.99
  • MACD
  • BIO 2.64
  • SRAD -0.46
  • Stochastic Oscillator
  • BIO 71.98
  • SRAD 5.85

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About SRAD Sportradar Group AG

Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing. Geographically, it operates in North America, Africa, AsiaPac & Middle East, Europe, and LATAM & Caribbean.

Share on Social Networks: